Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin A Patkar

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
CNS Drugs|May 28, 2013
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorderAshwin A Patkar, Chi-Un Pae
The American Journal of Psychiatry|June 3, 2010
Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypesAshwin A Patkar, Ting-Kai Li
Expert Review of Neurotherapeutics|February 9, 2007
Paroxetine: current status in psychiatryChi-Un Pae, Ashwin A Patkar
Journal of American College Health : J of ACH|March 5, 2008
The implementation of buprenorphine/naloxone in college health practicePeter A DeMaria, Ashwin A Patkar
Expert Opinion on Pharmacotherapy|September 8, 2011
Escitalopram for the treatment of major depressive disorder in youthJoon-Ho Ahn, Ashwin A Patkar
Journal of Addictive Diseases|April 19, 2007
Buprenorphine treatment: factors and first-hand experiences for providers to considerBradley R Meier, Ashwin A Patkar
CNS Drugs|May 28, 2013
Clinical issues in use of atypical antipsychotics for depressed patientsChi-Un Pae, Ashwin A Patkar
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 27, 2004
Pharmacotherapy of depression in pregnancyAshwin A Patkar, Louai Bilal, Prakash S Masand
CNS Drugs|January 25, 2011
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial dataChi-Un Pae, Andy Forbes, Ashwin A Patkar
Drugs of Today (Barcelona, Spain : 1998)|July 7, 2007
Transdermal selegilineAshwin A Patkar, Chi-Un Pae, Michael Zarzar
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
CNS Drugs|May 28, 2013
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorderAshwin A Patkar, Chi-Un Pae
The American Journal of Psychiatry|June 3, 2010
Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypesAshwin A Patkar, Ting-Kai Li
Expert Review of Neurotherapeutics|February 9, 2007
Paroxetine: current status in psychiatryChi-Un Pae, Ashwin A Patkar
Journal of American College Health : J of ACH|March 5, 2008
The implementation of buprenorphine/naloxone in college health practicePeter A DeMaria, Ashwin A Patkar
Expert Opinion on Pharmacotherapy|September 8, 2011
Escitalopram for the treatment of major depressive disorder in youthJoon-Ho Ahn, Ashwin A Patkar
Journal of Addictive Diseases|April 19, 2007
Buprenorphine treatment: factors and first-hand experiences for providers to considerBradley R Meier, Ashwin A Patkar
CNS Drugs|May 28, 2013
Clinical issues in use of atypical antipsychotics for depressed patientsChi-Un Pae, Ashwin A Patkar
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 27, 2004
Pharmacotherapy of depression in pregnancyAshwin A Patkar, Louai Bilal, Prakash S Masand
CNS Drugs|January 25, 2011
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial dataChi-Un Pae, Andy Forbes, Ashwin A Patkar
Drugs of Today (Barcelona, Spain : 1998)|July 7, 2007
Transdermal selegilineAshwin A Patkar, Chi-Un Pae, Michael Zarzar
Pageof 25